A Fixed Nitrous Oxide/oxygen Mixture As an Analgesic for Patients with Postherpetic Neuralgia: Study Protocol for a Randomized Controlled Trial

Overview

Journal Trials

Publisher Biomed Central

Specialties General Medicine
Pharmacology

Date 2021 Jan 7

PMID 33407845

Citations 1

Authors

Hai-Xiang Gao

Jun-Jun Zhang

Ning Liu

Yi Wang

Chun-Xiang Ma

Lu-Lu Gao

Qiang Liu

Ting-Ting Zhang

Yi-Ling Wang

Wen-Qiang Bao

Yu-Xiang Li

Affiliations

Soon will be listed here.

Abstract

Background: The pain management of postherpetic neuralgia (PHN) remains a major challenge, with no immediate relief. Nitrous oxide/oxygen mixture has the advantages of quick analgesic effect and well-tolerated. The purpose of this study is to investigate the analgesic effect and safety of nitrous oxide/oxygen mixture in patients with PHN.

Methods/design: This study is a single-center, two-group (1:1), randomized, placebo-controlled, double-blind clinical trial. A total of 42 patients with postherpetic neuralgia will be recruited and randomly divided into the intervention group and the control group. The control group will receive routine treatment plus oxygen, and the intervention group will receive routine treatment plus nitrous oxide/oxygen mixture. Data collectors, patients, and clinicians are all blind to the therapy. The outcomes of each group will be monitored at baseline (T0), 5 min (T1), and 15 min (T2) after the start of the therapy and at 5 min after the end of the therapy (T3). The primary outcome measure will be the pain intensity. Secondary outcomes included physiological parameters, adverse effects, patients' acceptance of analgesia, and satisfaction from patients.

Discussion: Previous studies have shown that nitrous oxide/oxygen mixture can effectively relieve cancer patients with breakthrough pain. This study will explore the analgesic effect of oxide/oxygen mixture on PHN. If beneficial to patients with PHN, it will contribute to the pain management of PHN.

Trial Registration: Chinese Clinical Trial Register ChiCTR1900023730 . Registered on 9 June 2019.

Citing Articles

Analgesic effect of premixed nitrous oxide/oxygen on removal of vacuum assisted closure dressings: randomized controlled trial study protocol.

Xing Y, Hou Y, Li C, Wang W, Fu C, Tang L J Orthop Surg Res. 2025; 20(1):231.

PMID: 40038774 PMC: 11877702. DOI: 10.1186/s13018-024-05397-1.

A nitrous oxide/oxygen fixed mixture to reduce pain induced by the hypodermic injection: study protocol for a randomized, controlled trial.

Zhang J, Yu P, Dang H, Feng C, Long X, Huang W Trials. 2024; 25(1):47.

PMID: 38218944 PMC: 10790270. DOI: 10.1186/s13063-024-07919-y.

References

Oster G, Harding G, Dukes E, Edelsberg J, Cleary P . Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain. 2005; 6(6):356-63. DOI: 10.1016/j.jpain.2005.01.359. View

Evans J, Buckley S, Alexander A, Gilpin A . Analgesia for the reduction of fractures in children: a comparison of nitrous oxide with intramuscular sedation. J Pediatr Orthop. 1995; 15(1):73-7. DOI: 10.1097/01241398-199501000-00016. View

Li Y, Han W, Tang H, Wu Y, Tang L, Yu J . Nitrous oxide-oxygen mixture during burn wound dressing: a double-blind randomized controlled study. CNS Neurosci Ther. 2013; 19(4):278-9. PMC: 6493482. DOI: 10.1111/cns.12061. View

Yokoe C, Hanamoto H, Sugimura M, Morimoto Y, Kudo C, Niwa H . A prospective, randomized controlled trial of conscious sedation using propofol combined with inhaled nitrous oxide for dental treatment. J Oral Maxillofac Surg. 2014; 73(3):402-9. DOI: 10.1016/j.joms.2014.09.014. View

Sampathkumar P, Drage L, Martin D . Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009; 84(3):274-80. PMC: 2664599. DOI: 10.4065/84.3.274. View

Bockenholt U . Measuring response styles in Likert items. Psychol Methods. 2016; 22(1):69-83. DOI: 10.1037/met0000106. View

Harden R, Kaye A, Kintanar T, Argoff C . Evidence-based guidance for the management of postherpetic neuralgia in primary care. Postgrad Med. 2013; 125(4):191-202. DOI: 10.3810/pgm.2013.07.2690. View

Liu Q, Wang Y, Luo X, Wang N, Chen P, Jin X . A fixed inhaled nitrous oxide/oxygen mixture as an analgesic for adult cancer patients with breakthrough pain: study protocol for a randomized controlled trial. Trials. 2017; 18(1):13. PMC: 5225628. DOI: 10.1186/s13063-016-1739-9. View

Juang C, Yen M, Horng H, Cheng C, Yu H, Chang C . Treatment of primary deep dyspareunia with laparoscopic uterosacral nerve ablation procedure: a pilot study. J Chin Med Assoc. 2006; 69(3):110-4. DOI: 10.1016/S1726-4901(09)70187-X. View

10.

Saarto T, Wiffen P . Antidepressants for neuropathic pain: a Cochrane review. J Neurol Neurosurg Psychiatry. 2010; 81(12):1372-3. DOI: 10.1136/jnnp.2008.144964. View

11.

Faddy S, Garlick S . A systematic review of the safety of analgesia with 50% nitrous oxide: can lay responders use analgesic gases in the prehospital setting?. Emerg Med J. 2005; 22(12):901-8. PMC: 1726638. DOI: 10.1136/emj.2004.020891. View

12.

Finnerup N, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin R . Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015; 14(2):162-73. PMC: 4493167. DOI: 10.1016/S1474-4422(14)70251-0. View

13.

Johnson R, Rice A . Clinical practice. Postherpetic neuralgia. N Engl J Med. 2014; 371(16):1526-33. DOI: 10.1056/NEJMcp1403062. View

14.

Bockbrader H, Wesche D, Miller R, Chapel S, Janiczek N, Burger P . A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010; 49(10):661-9. DOI: 10.2165/11536200-000000000-00000. View

15.

Delaney A, Colvin L, Fallon M, Dalziel R, Mitchell R, Fleetwood-Walker S . Postherpetic neuralgia: from preclinical models to the clinic. Neurotherapeutics. 2009; 6(4):630-7. PMC: 5084285. DOI: 10.1016/j.nurt.2009.07.005. View

16.

van Wijck A, Opstelten W, Moons K, van Essen G, Stolker R, Kalkman C . The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet. 2006; 367(9506):219-24. DOI: 10.1016/S0140-6736(06)68032-X. View

17.

Dworkin R, Gnann Jr J, Oaklander A, Raja S, Schmader K, Whitley R . Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008; 9(1 Suppl 1):S37-44. DOI: 10.1016/j.jpain.2007.10.008. View

18.

Arnold N, Messaoudi I . Herpes zoster and the search for an effective vaccine. Clin Exp Immunol. 2016; 187(1):82-92. PMC: 5167054. DOI: 10.1111/cei.12809. View

19.

Chen L, Arai H, Chen L, Chou M, Djauzi S, Dong B . Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. BMC Infect Dis. 2017; 17(1):213. PMC: 5353949. DOI: 10.1186/s12879-017-2198-y. View

20.

Nalamachu S, Morley-Forster P . Diagnosing and managing postherpetic neuralgia. Drugs Aging. 2012; 29(11):863-9. PMC: 3693437. DOI: 10.1007/s40266-012-0014-3. View